Market Insights Consumer OTC Pharmaceuticals

Wound Care - Austria

Austria

Revenue in the Wound Care market amounts to €34.08m in 2024. The market is expected to grow annually by 0.40% (CAGR 2024-2029).
In global comparison, most revenue is generated in the United States (€965m in 2024).
In relation to total population figures, per person revenues of €3.80 are generated in 2024.

Key regions: United States, Indonesia, Germany, Europe, United Kingdom

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Wound Care market in Austria is experiencing steady growth due to various factors such as an aging population, increasing prevalence of chronic wounds, and advancements in wound care technology.

Customer preferences: Customers in Austria are increasingly seeking wound care products that are effective, easy to use, and promote faster healing. They also prefer products that are comfortable to wear and minimize pain during the healing process. Additionally, there is a growing demand for wound care products that are environmentally friendly and sustainable.

Trends in the market: One of the key trends in the Austrian wound care market is the rising adoption of advanced wound care products. These products, such as hydrogels, foam dressings, and collagen dressings, offer better wound healing outcomes compared to traditional wound care products. The demand for these advanced products is driven by their ability to provide a moist wound environment, promote faster healing, and reduce the risk of infection. Another trend in the market is the increasing focus on prevention and early intervention. Healthcare professionals and patients are recognizing the importance of preventing wounds and addressing them at an early stage to prevent complications and reduce healthcare costs. This has led to a growing demand for preventive wound care products, such as pressure-relieving devices and wound dressings for high-risk individuals.

Local special circumstances: Austria has a well-developed healthcare system with a strong emphasis on quality care. This has resulted in a high standard of wound care services and products in the country. The government and healthcare institutions in Austria have implemented policies and guidelines to ensure the appropriate use of wound care products and promote best practices in wound management.

Underlying macroeconomic factors: The aging population in Austria is a significant driver of the wound care market. As the population ages, the prevalence of chronic wounds, such as pressure ulcers and diabetic foot ulcers, increases. This creates a growing demand for wound care products and services. Furthermore, advancements in wound care technology have played a crucial role in the growth of the market. Innovative products, such as bioactive dressings and negative pressure wound therapy systems, have improved the effectiveness and efficiency of wound healing. These technological advancements have contributed to the overall growth of the wound care market in Austria. In conclusion, the Wound Care market in Austria is witnessing steady growth due to factors such as an aging population, increasing prevalence of chronic wounds, and advancements in wound care technology. Customers in Austria prefer wound care products that are effective, easy to use, and promote faster healing. The market is characterized by the rising adoption of advanced wound care products and a focus on prevention and early intervention. Austria's well-developed healthcare system and the aging population are underlying macroeconomic factors that contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.